Chimerix Stock Net Income
| CMRX Stock | USD 0.89 0.01 1.11% |
Chimerix fundamentals help investors to digest information that contributes to Chimerix's financial success or failures. It also enables traders to predict the movement of Chimerix Stock. The fundamental analysis module provides a way to measure Chimerix's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Chimerix stock.
| Last Reported | Projected for Next Year | ||
| Net Loss | -82.1 M | -86.2 M | |
| Net Loss | -84.9 M | -89.1 M | |
| Net Income Applicable To Common Shares | 198 M | 207.9 M | |
| Net Loss | (0.93) | (0.97) | |
| Net Income Per E B T | 1.15 | 1.38 |
Chimerix | Net Income |
Chimerix Company Net Income Analysis
Chimerix's Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Current Chimerix Net Income | (82.09 M) |
Most of Chimerix's fundamental indicators, such as Net Income, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Chimerix is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Chimerix Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for Chimerix is extremely important. It helps to project a fair market value of Chimerix Stock properly, considering its historical fundamentals such as Net Income. Since Chimerix's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Chimerix's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Chimerix's interrelated accounts and indicators.
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Chimerix Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income |
|
Based on the recorded statements, Chimerix reported net income of (82.09 Million). This is 124.05% lower than that of the Biotechnology sector and 217.2% lower than that of the Health Care industry. The net income for all United States stocks is 114.38% higher than that of the company.
Chimerix Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Chimerix's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Chimerix could also be used in its relative valuation, which is a method of valuing Chimerix by comparing valuation metrics of similar companies.Chimerix is currently under evaluation in net income category among its peers.
Chimerix Current Valuation Drivers
We derive many important indicators used in calculating different scores of Chimerix from analyzing Chimerix's financial statements. These drivers represent accounts that assess Chimerix's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Chimerix's important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 112.7M | 300.3M | 546.1M | 162.9M | 85.3M | 81.0M | |
| Enterprise Value | 96.0M | 256.2M | 547.1M | 139.1M | 58.9M | 56.0M |
Chimerix Institutional Holders
Institutional Holdings refers to the ownership stake in Chimerix that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Chimerix's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Chimerix's value.| Shares | Acuitas Investments, Llc | 2024-09-30 | 796.4 K | Goldman Sachs Group Inc | 2024-06-30 | 695.6 K | Adage Capital Partners Gp Llc | 2024-06-30 | 600 K | Northern Trust Corp | 2024-09-30 | 585.9 K | Yakira Capital Management, Inc. | 2024-06-30 | 508.4 K | Tejara Capital Ltd | 2024-06-30 | 414.4 K | Bank Of New York Mellon Corp | 2024-06-30 | 388.5 K | Assenagon Asset Management Sa | 2024-09-30 | 320.9 K | State Street Corp | 2024-06-30 | 297.8 K | Ra Capital Management, Llc | 2024-09-30 | 8.8 M | Vanguard Group Inc | 2024-09-30 | 4.3 M |
Chimerix Fundamentals
| Return On Equity | -0.49 | ||||
| Return On Asset | -0.3 | ||||
| Operating Margin | (953.58) % | ||||
| Current Valuation | (54.64 M) | ||||
| Shares Outstanding | 89.94 M | ||||
| Shares Owned By Insiders | 6.62 % | ||||
| Shares Owned By Institutions | 45.90 % | ||||
| Number Of Shares Shorted | 1.52 M | ||||
| Price To Earning | (3.43) X | ||||
| Price To Book | 0.60 X | ||||
| Price To Sales | 509.07 X | ||||
| Revenue | 324 K | ||||
| Gross Profit | (36.49 M) | ||||
| EBITDA | (92.97 M) | ||||
| Net Income | (82.09 M) | ||||
| Cash And Equivalents | 42.79 M | ||||
| Cash Per Share | 0.49 X | ||||
| Total Debt | 1.3 M | ||||
| Debt To Equity | 0.1 % | ||||
| Current Ratio | 2.18 X | ||||
| Book Value Per Share | 1.51 X | ||||
| Cash Flow From Operations | (69.09 M) | ||||
| Short Ratio | 11.89 X | ||||
| Earnings Per Share | (0.93) X | ||||
| Target Price | 7.0 | ||||
| Number Of Employees | 72 | ||||
| Beta | 1.13 | ||||
| Market Capitalization | 80.94 M | ||||
| Total Asset | 212.77 M | ||||
| Retained Earnings | (795.52 M) | ||||
| Working Capital | 170.67 M | ||||
| Current Asset | 228.84 M | ||||
| Current Liabilities | 20.18 M | ||||
| Net Asset | 212.77 M |
About Chimerix Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Chimerix's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Chimerix using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Chimerix based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Chimerix Stock Analysis
When running Chimerix's price analysis, check to measure Chimerix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Chimerix is operating at the current time. Most of Chimerix's value examination focuses on studying past and present price action to predict the probability of Chimerix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Chimerix's price. Additionally, you may evaluate how the addition of Chimerix to your portfolios can decrease your overall portfolio volatility.